Low serum zinc and total antioxidant capacity levels in
individuals with premenstrual syndrome

AGAGÜNDÜZ, DUYGU; Kucukkasap Comert, Tugba; muşlu, özlem; ZENGIN, Hülya; GÜÇLÜ, AYLİN; Oztas, Bediye; AKARSU, SÜLEYMAN

doi:10.4274/gulhane.galenos.2021.80299

Low serum zinc and total antioxidant capacity levels in individuals with premenstrual syndrome

Tuğba KÜÇÜKKASAP CÖMERT, (Sağlık Bilimleri Üniversitesi, Gülhane Sağlık Bilimleri Fakültesi, Beslenme ve Diyetetik Bölümü, Ankara, Türkiye)

Duygu AĞAGÜNDÜZ, (Gazi Üniversitesi, Sağlık Bilimleri Fakültesi, Beslenme ve Diyetetik Bölümü, Ankara, Türkiye)

Özlem MUŞLU, (Yüksek İhtisas Üniversitesi, Sağlık Bilimleri Fakültesi, Beslenme ve Diyetetik Bölümü, Ankara, Türkiye)

Aylin GÜÇLÜ, (Yüksek İhtisas Üniversitesi, Sağlık Bilimleri Fakültesi, Hemşirelik Bölümü, Ankara, Türkiye)

Hülya ZENGİN, (Yüksek İhtisas Üniversitesi, Sağlık Bilimleri Fakültesi, Hemşirelik Bölümü, Ankara, Türkiye)

Bediye ÖZTAŞ, (Medipol Üniversitesi, Sağlık Bilimleri Fakültesi, Hemşirelik Bölümü, Ankara, Türkiye)

Süleyman AKARSU (Medicana International Hospital Ankara, Kadın Hastalıkları ve Doğum Kliniği, Ankara, Türkiye)

Gülhane Tıp Dergisi

17 3

Yıl: 2022 Cilt: 64 Sayı: 2 Sayfa Aralığı: 189 - 196 Metin Dili: İngilizce DOI: 10.4274/gulhane.galenos.2021.80299 İndeks Tarihi: 19-07-2022

Low serum zinc and total antioxidant capacity levels in individuals with premenstrual syndrome

Öz:

Aims: The aim of this study was to evaluate serum zinc (Zn) level, total antioxidant capacity (TAC) level, and nutritional status in premenstrual syndrome (PMS). Methods: This cross-sectional, single-center study and case-control study enrolled university students 18 to 28 years old. Serum TAC analysis was performed via the enzyme-linked immunosorbent assay. Serum Zn level was measured using atomic absorption spectrometry. Nutritional status was assessed using the 24-hour dietary recall. Results: The study population consisted of 110 individuals (mean±Sstandart deviation age: 20.3±1.9 years), 48 subjects with PMS, and 62 subjects without PMS. Individuals with PMS had lower serum Zn levels (28.04±31.40 µmol/L vs. 11.67±6.42 µmol/L, respectively), TAC levels (1.60±0.42 mmol/L vs. 1.47±0.10 mmol/L), and higher body mass index (22.30±02.71 kg/m2 vs. 23.73±3.44 kg/m2 ) than individuals without PMS. Individuals with PMS had lower fiber, polyunsaturated fatty acid (PUFA), vitamins E, vitamin B1, vitamin B2, vitamin B6, vitamin C, folate, and magnesium, and higher carbohydrate and sodium intake than those without PMS but the differences did not reach statistical significance. Serum TAC level, dietary antioxidant, and PUFA intake level were positively correlated (p<0.05), whereas serum TAC level was negatively correlated with dietary intake of protein, lipid, and carbohydrate intake (p<0.05). Conclusions: This study showed that serum Zn and TAC levels were lower in PMS, and serum TAC levels were correlated with dietary antioxidant intake.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Freeman EW. Premenstrual syndrome and premenstrual dysphoric disorder: definitions and diagnosis. Psychoneuroendocrinology. 2003;28(Suppl 3):25-37.
2. Halbreich U. The diagnosis of premenstrual syndromes and premenstrual dysphoric disorder--clinical procedures and research perspectives. Gynecol Endocrinol. 2004;19:320-334.
3. Steiner M, Pearlstein T, Cohen LS, et al. Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs. J Womens Health (Larchmt). 2006;15:57-69.
4. Alpay FB, Turhan NO. Intermittent versus continuous sertraline therapy in the treatment of premenstrual dysphoric disorders. Int J Fertil Womens Med. 2001;46:228-231.
5. Jarvis CI, Lynch AM, Morin AK. Management Strategies for Premenstrual syndrome/premenstrual dysphoric disorder. Ann Pharmacother. 2008;42:967-978.
6. A DM, K S, A D, Sattar K. Epidemiology of Premenstrual Syndrome (PMS)-A Systematic Review and Meta-Analysis Study. J Clin Diagn Res. 2014;8:106-109. Erratum in: J Clin Diagn Res. 2015;9:ZZ05.
7. Kahyaoglu Sut H, Mestogullari E. Effect of Premanstrual Syndrome on Work-Related Quality of Life in Turkish Nurses. Saf Health Work. 2016;7:78-82.
8. Goker A, Artunc-Ulkumen B, Aktenk F, Ikiz N. Premenstrual syndrome in Turkish medical students and their quality of life. J Obstet Gynaecol. 2015;35:275-278.
9. Hantsoo L, Epperson CN. Allopregnanolone in premenstrual dysphoric disorder (PMDD): Evidence for dysregulated sensitivity to GABA-A receptor modulating neuroactive steroids across the menstrual cycle. Neurobiol Stress. 2020;12:100213.
10. Szmidt MK, Granda D, Sicinska E, et al. Primary Dysmenorrhea in Relation to Oxidative Stress and Antioxidant Status: A Systematic Review of Case-Control Studies. Antioxidants (Basel). 2020;15:9:994.
11. Granda D, Szmidt MK, Kaluza J. Is Premenstrual Syndrome Associated with Inflammation, Oxidative Stress and Antioxidant Status? A Systematic Review of Case-Control and CrossSectional Studies. Antioxidants (Basel). 2021;10:604.
12. Duvan CI, Cumaoglu A, Turhan NO, Karasu C, Kafali H. Oxidant/antioxidant status in premenstrual syndrome. Arch Gynecol Obstet. 2011;283:299-304.
13. Hofmeister S, Bodden S. Premenstrual Syndrome and Premenstrual Dysphoric Disorder. Am Fam Physician. 2016;94:236-240.
14. Khanzode SD, Dakhale GN, Khanzode SS, Saoji A, Palasodkar R. Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors. Redox Rep. 2003;8:365-370.
15. Arranz L, Guayerbas N, De la Fuente M. Impairment of several immune functions in anxious women. J Psychosom Res. 2007;62:1-8.
16. Jehan S, Auguste E, Hussain M, et al. Sleep and Premenstrual Syndrome. J Sleep Med Disord. 2016;3:1061.
17. Ozcan H, Oral E, Gulec M, et al. Total oxidant–antioxidant and paraoxonase-1 levels in premenstrual dysphoric disorder: a follow-up study. Psychiatry and Clinical Psychopharmacology. 2017;27:116-124.
18. Teimoori B, Ghasemi M, Hoseini ZS, Razavi M. The Efficacy of Zinc Administration in the Treatment of Primary Dysmenorrhea. Oman Med J. 2016;31:107-111.
19. Gold EB, Wells C, Rasor MO. The Association of Inflammation with Premenstrual Symptoms. J Womens Health (Larchmt). 2016;25:865-874.
20. Barcikowska Z, Rajkowska-Labon E, Grzybowska ME, et al. Inflammatory Markers in Dysmenorrhea and Therapeutic Options. Int J Environ Res Public Health. 2020;17:1191.
21. Bertone-Johnson ER, Ronnenberg AG, Houghton SC, et al. Association of inflammation markers with menstrual symptom severity and premenstrual syndrome in young women. Hum Reprod. 2014;29:1987-1994.
22. Jafari F, Amani R, Tarrahi MJ. Effect of Zinc Supplementation on Physical and Psychological Symptoms, Biomarkers of Inflammation, Oxidative Stress, and Brain-Derived Neurotrophic Factor in Young Women with Premenstrual Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial. Biol Trace Elem Res. 2020;194:89–95.
23. Petrilli MA, Kranz TM, Kleinhaus K, et al. The Emerging Role for Zinc in Depression and Psychosis. Front Pharmacol. 2017;30:8:414.
24. Pekcan G. Beslenme Durumunun Saptanması. Ankara: Klasmat Matbaacılık, 2008.
25. Gençdoğan B. Premenstrual Sendrom İçin Yeni Bir Ölçek. Türkiye’de Psikiyatri Derg. 2006;8:81-87.
26. Karaca A, Turnagöl HH. Çalışan bireylerde üç farklı fiziksel aktivite anketinin güvenirliği ve geçerliliği. Spor Bilimleri Dergisi. 2007;18:68-84.
27. Grønli O, Kvamme JM, Friborg O, Wynn R. Zinc deficiency is common in several psychiatric disorders. PLoS One. 2013;8:e82793.
28. Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem. 2004;37:277-285.
29. Bebis, Nutrition Data Base Software. Data Base: The German Food Code and Nutrient Data Base (BLS II.3, 1999) with additions from USDA-sr and other sources, Istanbul, 2004.
30. Carlsen MH, Halvorsen BL, Holte K, et al. The total antioxidant content of more than 3100 foods, beverages, spices, herbs and supplements used worldwide. Nutr J. 2010;9:3.
31. Houghton SC, Manson JE, Whitcomb BW, et al. Carbohydrate and fiber intake and the risk of premenstrual syndrome. Eur J Clin Nutr. 2018;72:861-870.
32. Bertone-Johnson ER, Hankinson SE, Forger NG, et al. Plasma 25-hydroxyvitamin D and risk of premenstrual syndrome in a prospective cohort study. BMC Womens Health. 2014;14:56.
33. Masho SW, Adera T, South Paul J. Obesity as a risk factor for premenstrual syndrome. J Psychosom Obstet Gynaecol. 2005;26:33-39.
34. Haghighi ES, Jahromi MK, Daryano Osh F. Relationship between cardiorespiratory fitness, habitual physical activity, body mass index and premenstrual symptoms in collegiate students. J Sports Med Phys Fitness. 2015;55:663-667.
35. Bertone-Johnson ER, Hankinson SE, Willett WC, Johnson SR, Manson JE. Adiposity and the development of premenstrual syndrome. J Womens Health (Larchmt). 2010;19:1955-1962.
36. Costanian C, Akiki Z, Rabah Z, Daou S, Assaad S. Factors associated with premenstrual syndrome and its different symptom domains among university students in Lebanon. Int J Womens Health Wellness. 2018;4:068.
37. Zellner DA, Garriga-Trillo A, Centeno S, Wadsworth E. Chocolate craving and the menstrual cycle. Appetite. 2004;42:119-121.
38. Işgın K, Büyüktuncer Z. Premenstrual sendromda beslenme yaklaşımı. Turk Hij Den Biyol Derg. 2017;74:249-260.
39. Balat O, Dikensoy E, Ugur MG, Atmaca R, Cekmen M, Yurekli M. Malon dialdehyde, nitrite and adrenomedullin levels in patients with premenstrual syndrome. Arch Gynecol Obstet. 2007;275:361-365.
40. Tuladhar ET, Rao A. Plasma protein oxidation and total antioxidant power in premenstrual syndrome. Asian Pac J Trop Med. 2010;3:237-240.
41. Rosenfeld R, Livne D, Nevo O, et al. Hormonal and volume dysregulation in women with premenstrual syndrome. Hypertension. 2008;51:1225-1230.
42. Frankel RA, Michels KA, Kim K, et al. Serum antioxidant vitamin concentrations and oxidative stress markers associated with symptoms and severity of premenstrual syndrome: a prospective cohort study. BMC Womens Health. 2021;21:49.
43. Abdi F, Ozgoli G, Rahnemaie FS. A systematic review of the role of vitamin D and calcium in premenstrual syndrome. Obstet Gynecol Sci. 2019;62:73-86.
44. Szewczyk B. Zinc homeostasis and neurodegenerative disorders. Front Aging Neurosci. 2013;19:33.
45. Mohebbi Dehnavi Z, Jafarnejad F, Sadeghi Goghary S. The effect of 8 weeks aerobic exercise on severity of physical symptoms of premenstrual syndrome: a clinical trial study. BMC Womens Health. 2018;31:80.
46. Morino S, Egawa M, Hirata H, Nishimura F, Aoyama T. Association between premenstrual syndrome and daily physical activity level. J Womens Health. 2016;5:1-4.

APA	Kucukkasap Comert T, AGAGÜNDÜZ D, muşlu ö, GÜÇLÜ A, ZENGIN H, Oztas B, AKARSU S (2022). Low serum zinc and total antioxidant capacity levels in individuals with premenstrual syndrome . , 189 - 196. 10.4274/gulhane.galenos.2021.80299
Chicago	Kucukkasap Comert Tugba,AGAGÜNDÜZ DUYGU,muşlu özlem,GÜÇLÜ AYLİN,ZENGIN Hülya,Oztas Bediye,AKARSU SÜLEYMAN Low serum zinc and total antioxidant capacity levels in individuals with premenstrual syndrome . (2022): 189 - 196. 10.4274/gulhane.galenos.2021.80299
MLA	Kucukkasap Comert Tugba,AGAGÜNDÜZ DUYGU,muşlu özlem,GÜÇLÜ AYLİN,ZENGIN Hülya,Oztas Bediye,AKARSU SÜLEYMAN Low serum zinc and total antioxidant capacity levels in individuals with premenstrual syndrome . , 2022, ss.189 - 196. 10.4274/gulhane.galenos.2021.80299
AMA	Kucukkasap Comert T,AGAGÜNDÜZ D,muşlu ö,GÜÇLÜ A,ZENGIN H,Oztas B,AKARSU S Low serum zinc and total antioxidant capacity levels in individuals with premenstrual syndrome . . 2022; 189 - 196. 10.4274/gulhane.galenos.2021.80299
Vancouver	Kucukkasap Comert T,AGAGÜNDÜZ D,muşlu ö,GÜÇLÜ A,ZENGIN H,Oztas B,AKARSU S Low serum zinc and total antioxidant capacity levels in individuals with premenstrual syndrome . . 2022; 189 - 196. 10.4274/gulhane.galenos.2021.80299
IEEE	Kucukkasap Comert T,AGAGÜNDÜZ D,muşlu ö,GÜÇLÜ A,ZENGIN H,Oztas B,AKARSU S "Low serum zinc and total antioxidant capacity levels in individuals with premenstrual syndrome ." , ss.189 - 196, 2022. 10.4274/gulhane.galenos.2021.80299
ISNAD	Kucukkasap Comert, Tugba vd. "Low serum zinc and total antioxidant capacity levels in individuals with premenstrual syndrome ". (2022), 189-196. https://doi.org/10.4274/gulhane.galenos.2021.80299

APA	Kucukkasap Comert T, AGAGÜNDÜZ D, muşlu ö, GÜÇLÜ A, ZENGIN H, Oztas B, AKARSU S (2022). Low serum zinc and total antioxidant capacity levels in individuals with premenstrual syndrome . Gülhane Tıp Dergisi, 64(2), 189 - 196. 10.4274/gulhane.galenos.2021.80299
Chicago	Kucukkasap Comert Tugba,AGAGÜNDÜZ DUYGU,muşlu özlem,GÜÇLÜ AYLİN,ZENGIN Hülya,Oztas Bediye,AKARSU SÜLEYMAN Low serum zinc and total antioxidant capacity levels in individuals with premenstrual syndrome . Gülhane Tıp Dergisi 64, no.2 (2022): 189 - 196. 10.4274/gulhane.galenos.2021.80299
MLA	Kucukkasap Comert Tugba,AGAGÜNDÜZ DUYGU,muşlu özlem,GÜÇLÜ AYLİN,ZENGIN Hülya,Oztas Bediye,AKARSU SÜLEYMAN Low serum zinc and total antioxidant capacity levels in individuals with premenstrual syndrome . Gülhane Tıp Dergisi, vol.64, no.2, 2022, ss.189 - 196. 10.4274/gulhane.galenos.2021.80299
AMA	Kucukkasap Comert T,AGAGÜNDÜZ D,muşlu ö,GÜÇLÜ A,ZENGIN H,Oztas B,AKARSU S Low serum zinc and total antioxidant capacity levels in individuals with premenstrual syndrome . Gülhane Tıp Dergisi. 2022; 64(2): 189 - 196. 10.4274/gulhane.galenos.2021.80299
Vancouver	Kucukkasap Comert T,AGAGÜNDÜZ D,muşlu ö,GÜÇLÜ A,ZENGIN H,Oztas B,AKARSU S Low serum zinc and total antioxidant capacity levels in individuals with premenstrual syndrome . Gülhane Tıp Dergisi. 2022; 64(2): 189 - 196. 10.4274/gulhane.galenos.2021.80299
IEEE	Kucukkasap Comert T,AGAGÜNDÜZ D,muşlu ö,GÜÇLÜ A,ZENGIN H,Oztas B,AKARSU S "Low serum zinc and total antioxidant capacity levels in individuals with premenstrual syndrome ." Gülhane Tıp Dergisi, 64, ss.189 - 196, 2022. 10.4274/gulhane.galenos.2021.80299
ISNAD	Kucukkasap Comert, Tugba vd. "Low serum zinc and total antioxidant capacity levels in individuals with premenstrual syndrome ". Gülhane Tıp Dergisi 64/2 (2022), 189-196. https://doi.org/10.4274/gulhane.galenos.2021.80299